{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:05:39Z","timestamp":1790503539586,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Basic Research Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.bmcl.2019.05.027","type":"journal-article","created":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T12:07:37Z","timestamp":1558008457000},"page":"1719-1726","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Chemically synthesized LYRM03 could inhibit the metastasis of human breast cancer MDA-MB-231 cells in vitro and in vivo"],"prefix":"10.1016","volume":"29","author":[{"given":"Yun-kai","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-dong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-dong","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding-jian","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-qing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2019.05.027_b0005","first-page":"31","article-title":"Apoptosis induction of human leukemia cells by Streptomyces sp. SY-103 metabolites through activation of caspase-3 and inactivation of Akt","volume":"25","author":"Jeong","year":"2010","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.bmcl.2019.05.027_b0010","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1021\/np068054v","article-title":"Natural products as sources of new drugs over the last 25 years","volume":"70","author":"Newman","year":"2007","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmcl.2019.05.027_b0015","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3681094","article-title":"Microbial and natural metabolites that inhibit splicing: a powerful alternative for cancer treatment","author":"Martinez-Montiel","year":"2016","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.bmcl.2019.05.027_b0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.neuroscience.2015.07.082","article-title":"The Streptomyces metabolite anhydroexfoliamycin ameliorates hallmarks of Alzheimer\u2019s disease in vitro and in vivo","volume":"305","author":"Leiros","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.bmcl.2019.05.027_b0025","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1128\/AEM.01337-10","article-title":"Mycolic acid-containing bacteria induce natural-product biosynthesis in Streptomyces species","volume":"77","author":"Onaka","year":"2011","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.bmcl.2019.05.027_b0030","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/1439-7633(20020703)3:7<619::AID-CBIC619>3.0.CO;2-9","article-title":"Big effects from small changes: possible ways to explore nature\u2019s chemical diversity","volume":"3","author":"Bode","year":"2002","journal-title":"Chembiochem"},{"key":"10.1016\/j.bmcl.2019.05.027_b0035","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1128\/AAC.13.1.104","article-title":"Actinomycin biosynthesis by protoplasts derived from Streptomyces parvulus","volume":"13","author":"Hitchcock","year":"1978","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2019.05.027_b0040","first-page":"94","article-title":"Preliminary identification of Streptomyces sp. DT-08 producing a novel lipopeptide antibiotic","volume":"40","author":"Shuang","year":"2009","journal-title":"J China Pharm Univ"},{"key":"10.1016\/j.bmcl.2019.05.027_b0045","doi-asserted-by":"crossref","first-page":"82","DOI":"10.7164\/antibiotics.50.82","article-title":"Phebestin, a new inhibitor of aminopeptidase N, produced by Streptomyces sp. MJ716-m3","volume":"50","author":"Nagai","year":"1997","journal-title":"J Antibiotics"},{"key":"10.1016\/j.bmcl.2019.05.027_b0050","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1080\/00032719.2013.800538","article-title":"UPLC-MS-based metabolomic study of Streptomyces Strain HCCB10043 under different pH conditions reveals important pathways affecting the biosynthesis of A21978C compounds","volume":"46","author":"Rao","year":"2013","journal-title":"Anal Lett"},{"key":"10.1016\/j.bmcl.2019.05.027_b0055","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1016\/j.bmcl.2011.02.066","article-title":"Design and synthesis of several small-size HTLV-I protease inhibitors with different hydrophilicity profiles","volume":"21","author":"Nguyen","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2019.05.027_b0060","doi-asserted-by":"crossref","first-page":"97","DOI":"10.7164\/antibiotics.29.97","article-title":"Bestatin, an inhibitor of aminopeptidase B, produced by actinomycetes","volume":"29","author":"Umezawa","year":"1976","journal-title":"J Antibiotics"},{"key":"10.1016\/j.bmcl.2019.05.027_b0065","doi-asserted-by":"crossref","first-page":"10127","DOI":"10.1039\/C5OB01821H","article-title":"Total synthesis and absolute stereochemistry of the proteasome inhibitors cystargolides A and B","volume":"13","author":"Tello-Aburto","year":"2015","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.bmcl.2019.05.027_b0070","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00216-011-5093-1","article-title":"A new aminopeptidase inhibitor from Streptomyces strain HCCB10043 found by UPLC-MS","volume":"401","author":"Rao","year":"2011","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.bmcl.2019.05.027_b0075","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1080\/14786419.2013.811661","article-title":"A new antibacterial lipopeptide found by UPLC-MS from an actinomycete Streptomyces sp. HCCB10043","volume":"27","author":"Rao","year":"2013","journal-title":"Nat Prod Res"},{"key":"10.1016\/j.bmcl.2019.05.027_b0080","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1096\/fasebj.7.2.8440407","article-title":"Aminopeptidases: structure and function","volume":"7","author":"Taylor","year":"1993","journal-title":"FASEB J"},{"key":"10.1016\/j.bmcl.2019.05.027_b0085","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/jcp.47.1.43","article-title":"Expression of aminopeptidase-n (CD 13) in normal tissues and malignant neoplasms of epithelial and lymphoid origin","volume":"47","author":"Dixon","year":"1994","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.bmcl.2019.05.027_b0090","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s12032-011-9984-y","article-title":"Prognostic value of matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9) and aminopeptidase N\/CD13 in breast cancer patients","volume":"29","author":"Ranogajec","year":"2012","journal-title":"Med Oncol (Northwood, London, England)"},{"key":"10.1016\/j.bmcl.2019.05.027_b0095","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1136\/ijgc-00009577-200609000-00010","article-title":"Expression of aminopeptidase N\/CD13 in human ovarian cancers","volume":"16","author":"Surowiak","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.bmcl.2019.05.027_b0100","first-page":"1503","article-title":"Clinical significance of aminopeptidase N\/CD13 expression in human pancreatic carcinoma","volume":"9","author":"Ikeda","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bmcl.2019.05.027_b0105","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1053\/gast.2002.31095","article-title":"Aminopeptidase N is involved in cell motility and angiogenesis: its clinical significance in human colon cancer","volume":"122","author":"Hashida","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bmcl.2019.05.027_b0110","first-page":"4688","article-title":"CD13 overexpression promotes rectal cancer cell proliferation by increasing VEGF expression","volume":"11","author":"Xu","year":"2018","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.bmcl.2019.05.027_b0115","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1073\/pnas.1120790109","article-title":"Cooperative effects of aminopeptidase N (CD13) expressed by nonmalignant and cancer cells within the tumor microenvironment","volume":"109","author":"Guzman-Rojas","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmcl.2019.05.027_b0120","doi-asserted-by":"crossref","unstructured":"Azimi A, et al. Silencing FLI or targeting CD13\/ANPEP lead to dephosphorylation of EPHA2, a mediator of BRAF inhibitor resistance, and induce growth arrest or apoptosis in melanoma cells. 8, e3029 (2017).","DOI":"10.1038\/cddis.2017.406"},{"key":"10.1016\/j.bmcl.2019.05.027_b0125","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.tranon.2018.08.004","article-title":"Aminopeptidase N (CD13): expression, prognostic impact, and use as therapeutic target for tissue factor induced tumor vascular infarction in soft tissue sarcoma","volume":"11","author":"Kessler","year":"2018","journal-title":"Transl Oncol"},{"key":"10.1016\/j.bmcl.2019.05.027_b0130","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.lungcan.2017.09.013","article-title":"CD13 as target for tissue factor induced tumor vascular infarction in small cell lung cancer","volume":"113","author":"Schmidt","year":"2017","journal-title":"Lung Cancer (Amsterdam, Netherlands)"},{"key":"10.1016\/j.bmcl.2019.05.027_b0135","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/j.bbagen.2018.05.013","article-title":"A functional glycoproteomics approach identifies CD13 as a novel E-selectin ligand in breast cancer","volume":"1862","author":"Carrascal","year":"2018","journal-title":"Biochim Biophys Acta, Gen Subj"},{"key":"10.1016\/j.bmcl.2019.05.027_b0140","first-page":"311","article-title":"Breast cancer metastasis","volume":"9","author":"Scully","year":"2012","journal-title":"Cancer Genomics Proteomics"},{"key":"10.1016\/j.bmcl.2019.05.027_b0145","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/aps.2016.141","article-title":"LYRM03, an ubenimex derivative, attenuates LPS-induced acute lung injury in mice by suppressing the TLR4 signaling pathway","volume":"38","author":"Hui-qiong","year":"2017","journal-title":"Acta Pharmacol Sinica"},{"key":"10.1016\/j.bmcl.2019.05.027_b0150","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1046\/j.1365-2249.1998.00513.x","article-title":"Regulation of the expression of aminopeptidase A, aminopeptidase N\/CD13 and dipeptidylpeptidase IV\/CD26 in renal carcinoma cells and renal tubular epithelial cells by cytokines and cAMP-increasing mediators","volume":"111","author":"Kehlen","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.bmcl.2019.05.027_b0155","doi-asserted-by":"crossref","DOI":"10.1002\/mc.22600","article-title":"A CD13-targeting peptide integrated protein inhibits human liver cancer growth by killing cancer stem cells and suppressing angiogenesis","volume":"56","author":"Zheng","year":"2017","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.bmcl.2019.05.027_b0160","first-page":"722","article-title":"Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis","volume":"60","author":"Pasqualini","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.bmcl.2019.05.027_b0165","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/cr.2008.24","article-title":"MicroRNA-21 targets tumor suppressor genes in invasion and metastasis","volume":"18","author":"Zhu","year":"2008","journal-title":"Cell Res"},{"key":"10.1016\/j.bmcl.2019.05.027_b0170","article-title":"ZMYND8 acetylation mediates HIF-dependent breast cancer progression and metastasis","volume":"1937\u20131955","author":"Chen","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bmcl.2019.05.027_b0175","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ijc.21089","article-title":"CD13 (aminopeptidase N) can associate with tumor-associated antigen L6 and enhance the motility of human lung cancer cells","volume":"116","author":"Chang","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bmcl.2019.05.027_b0180","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/cncr.28914","article-title":"Subtyping of triple-negative breast cancer: implications for therapy","volume":"121","author":"Abramson","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.bmcl.2019.05.027_b0185","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/283139a0","article-title":"The pathogenesis of cancer metastasis","volume":"283","author":"Poste","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2019.05.027_b0190","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10549-011-1499-x","article-title":"Signaling mechanism of cell adhesion molecules in breast cancer metastasis: potential therapeutic targets","volume":"128","author":"Dong-Mei","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.bmcl.2019.05.027_b0195","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.mcn.2008.05.020","article-title":"Cadherin-6 gene regulatory patterns in the postnatal mouse brain","volume":"39","author":"Inoue","year":"2008","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.bmcl.2019.05.027_b0200","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1242\/dev.125.5.803","article-title":"Differential expression and function of cadherin-6 during renal epithelium development","volume":"125","author":"Cho","year":"1998","journal-title":"Development (Cambridge, England)"},{"key":"10.1016\/j.bmcl.2019.05.027_b0205","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/dbio.1996.8501","article-title":"Cadherin-6 expression transiently delineates specific rhombomeres, other neural tube subdivisions, and neural crest subpopulations in mouse embryos","volume":"183","author":"Inoue","year":"1997","journal-title":"Dev Biol"},{"key":"10.1016\/j.bmcl.2019.05.027_b0210","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/onc.2016.237","article-title":"Cadherin-6 promotes EMT and cancer metastasis by restraining autophagy","volume":"36","author":"Gugnoni","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.bmcl.2019.05.027_b0215","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1023\/A:1006538200886","article-title":"Proteolysis of extracellular matrix by invadopodiafacilitates human breast cancer cell invasion and ismediated by matrix metalloproteinases","volume":"16","author":"Kelly","year":"1998","journal-title":"Clin Exp Metastasis"}],"container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X19303269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X19303269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:29:13Z","timestamp":1760772553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X19303269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":43,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0960894X19303269"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2019.05.027","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemically synthesized LYRM03 could inhibit the metastasis of human breast cancer MDA-MB-231 cells in vitro and in vivo","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2019.05.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}